Trial Profile
Mechanisms of antiproteinuric effects of azelnidipine in hypertensive patients with type 2 diabetes mellitus
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 21 Jul 2015
Price :
$35
*
At a glance
- Drugs Azelnidipine (Primary) ; Amlodipine; Angiotensin receptor antagonists
- Indications Essential hypertension; Proteinuria
- Focus Pharmacodynamics
- Acronyms MAP in DM
- 13 Mar 2012 New trial record